Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 32790 | 147.115 |
09:34 ET | 11488 | 146.645 |
09:36 ET | 6086 | 147.05 |
09:38 ET | 12824 | 147.0356 |
09:39 ET | 4497 | 146.785 |
09:41 ET | 3259 | 147.09 |
09:43 ET | 8651 | 146.4 |
09:45 ET | 10105 | 146.7 |
09:48 ET | 8926 | 145.18 |
09:50 ET | 3699 | 145.54 |
09:52 ET | 6401 | 146.12 |
09:54 ET | 2989 | 146.26 |
09:56 ET | 10909 | 147.82 |
09:57 ET | 18193 | 148.51 |
09:59 ET | 8124 | 148.205 |
10:01 ET | 3579 | 147.574 |
10:03 ET | 5426 | 147.5442 |
10:06 ET | 3717 | 147.2371 |
10:08 ET | 3827 | 147.37 |
10:10 ET | 5788 | 147.2 |
10:12 ET | 6154 | 146.5 |
10:14 ET | 3309 | 145.975 |
10:15 ET | 8767 | 146.19 |
10:17 ET | 4148 | 146.2399 |
10:19 ET | 6514 | 146.24 |
10:21 ET | 4111 | 146.2748 |
10:24 ET | 6574 | 146.57 |
10:26 ET | 3857 | 146.58 |
10:28 ET | 4097 | 146.53 |
10:30 ET | 4787 | 146.28 |
10:32 ET | 4492 | 146.21 |
10:33 ET | 4129 | 145.83 |
10:35 ET | 3169 | 145.76 |
10:37 ET | 6936 | 145.7724 |
10:39 ET | 2455 | 145.82 |
10:42 ET | 3486 | 145.905 |
10:44 ET | 3503 | 145.93 |
10:46 ET | 7229 | 146.38 |
10:48 ET | 11611 | 147.05 |
10:50 ET | 7138 | 147.235 |
10:51 ET | 3736 | 146.6588 |
10:53 ET | 894 | 146.7836 |
10:55 ET | 2791 | 146.895 |
10:57 ET | 5493 | 146.85 |
11:00 ET | 2368 | 146.57 |
11:02 ET | 2184 | 146.9725 |
11:04 ET | 2745 | 146.54 |
11:06 ET | 3300 | 146.56 |
11:08 ET | 4363 | 146.5942 |
11:09 ET | 1334 | 146.55 |
11:11 ET | 800 | 146.525 |
11:13 ET | 11905 | 145.81 |
11:15 ET | 1636 | 146.3 |
11:18 ET | 1886 | 145.91 |
11:20 ET | 793 | 145.78 |
11:22 ET | 760 | 145.8856 |
11:24 ET | 1376 | 145.68 |
11:26 ET | 1350 | 145.85 |
11:27 ET | 11995 | 146.175 |
11:29 ET | 1160 | 146.39 |
11:31 ET | 4272 | 146.545 |
11:33 ET | 3728 | 146.3482 |
11:36 ET | 2706 | 146.4787 |
11:38 ET | 2597 | 146.94 |
11:40 ET | 6226 | 146.34 |
11:42 ET | 7208 | 146.1 |
11:44 ET | 1910 | 146.36 |
11:45 ET | 5152 | 146.46 |
11:47 ET | 2028 | 146.59 |
11:49 ET | 2676 | 146.605 |
11:51 ET | 3289 | 146.49 |
11:54 ET | 7959 | 146.35 |
11:56 ET | 4725 | 146.33 |
11:58 ET | 2508 | 146.21 |
12:00 ET | 1561 | 146.22 |
12:02 ET | 2350 | 145.985 |
12:03 ET | 1985 | 145.97 |
12:05 ET | 871 | 145.8 |
12:07 ET | 4952 | 145.801 |
12:09 ET | 10609 | 145.72 |
12:12 ET | 7995 | 145.93 |
12:14 ET | 1903 | 146.0399 |
12:16 ET | 2696 | 146.42 |
12:18 ET | 614 | 146.2 |
12:20 ET | 1427 | 146.22 |
12:21 ET | 2955 | 146.51 |
12:23 ET | 5442 | 146.04 |
12:25 ET | 650 | 146 |
12:27 ET | 4612 | 145.97 |
12:30 ET | 1384 | 146.0014 |
12:32 ET | 2781 | 146.03 |
12:34 ET | 3795 | 146.1 |
12:36 ET | 1099 | 145.96 |
12:38 ET | 2511 | 146.035 |
12:39 ET | 1904 | 146.215 |
12:41 ET | 1911 | 146.17 |
12:43 ET | 2964 | 146.3 |
12:45 ET | 4314 | 146.43 |
12:48 ET | 2366 | 146.39 |
12:50 ET | 1541 | 146.23 |
12:52 ET | 3156 | 146.64 |
12:54 ET | 2110 | 146.825 |
12:56 ET | 1221 | 146.84 |
12:57 ET | 800 | 146.72 |
12:59 ET | 5636 | 146.49 |
01:01 ET | 2816 | 146.49 |
01:03 ET | 3677 | 146.71 |
01:06 ET | 2200 | 146.8 |
01:08 ET | 1840 | 146.73 |
01:10 ET | 654 | 146.7062 |
01:12 ET | 420 | 146.63 |
01:14 ET | 8867 | 146.5483 |
01:15 ET | 16524 | 146.09 |
01:17 ET | 2517 | 146.135 |
01:19 ET | 2386 | 146.005 |
01:21 ET | 5343 | 145.59 |
01:24 ET | 4517 | 145.68 |
01:26 ET | 2424 | 145.665 |
01:28 ET | 5255 | 145.65 |
01:30 ET | 200 | 145.76 |
01:32 ET | 984 | 145.7 |
01:33 ET | 2891 | 145.82 |
01:35 ET | 1133 | 145.795 |
01:37 ET | 2239 | 145.58 |
01:39 ET | 2256 | 145.785 |
01:42 ET | 1726 | 145.871 |
01:44 ET | 1100 | 145.995 |
01:46 ET | 11640 | 146.025 |
01:48 ET | 2992 | 145.95 |
01:50 ET | 1088 | 145.95 |
01:51 ET | 1318 | 145.985 |
01:53 ET | 1259 | 146.08 |
01:55 ET | 3133 | 146.0904 |
01:57 ET | 1094 | 146.17 |
02:00 ET | 1168 | 146.175 |
02:02 ET | 1794 | 146.34 |
02:04 ET | 999 | 146.24 |
02:06 ET | 1298 | 145.926 |
02:08 ET | 1093 | 146.07 |
02:09 ET | 1584 | 145.99 |
02:11 ET | 3206 | 145.94 |
02:13 ET | 2135 | 145.81 |
02:15 ET | 2647 | 145.725 |
02:18 ET | 1956 | 145.71 |
02:20 ET | 994 | 145.595 |
02:22 ET | 2922 | 145.58 |
02:24 ET | 3536 | 145.56 |
02:26 ET | 3273 | 145.53 |
02:27 ET | 3062 | 145.46 |
02:29 ET | 896 | 145.44 |
02:31 ET | 1139 | 145.7 |
02:33 ET | 2644 | 145.655 |
02:36 ET | 1289 | 145.62 |
02:38 ET | 2626 | 145.62 |
02:40 ET | 1100 | 145.505 |
02:42 ET | 4837 | 145.55 |
02:44 ET | 4780 | 145.6 |
02:45 ET | 1162 | 145.546 |
02:47 ET | 7196 | 145.44 |
02:49 ET | 851 | 145.4 |
02:51 ET | 1616 | 145.555 |
02:54 ET | 9034 | 145.7065 |
02:56 ET | 1368 | 145.6501 |
02:58 ET | 3106 | 145.49 |
03:00 ET | 600 | 145.435 |
03:02 ET | 2018 | 145.59 |
03:03 ET | 1770 | 145.64 |
03:05 ET | 760 | 145.584 |
03:07 ET | 756 | 145.67 |
03:09 ET | 884 | 145.71 |
03:12 ET | 3637 | 145.392 |
03:14 ET | 500 | 145.42 |
03:16 ET | 2970 | 145.4399 |
03:18 ET | 2464 | 145.45 |
03:20 ET | 14056 | 145.0728 |
03:21 ET | 2803 | 145.0306 |
03:23 ET | 1858 | 145.1035 |
03:25 ET | 3024 | 145.2362 |
03:27 ET | 2278 | 145.34 |
03:30 ET | 4648 | 145.265 |
03:32 ET | 3268 | 145.16 |
03:34 ET | 3108 | 145.25 |
03:36 ET | 3556 | 145.125 |
03:38 ET | 3384 | 145.28 |
03:39 ET | 2354 | 145.23 |
03:41 ET | 6586 | 145.15 |
03:43 ET | 4769 | 145.335 |
03:45 ET | 9340 | 145.19 |
03:48 ET | 7937 | 144.99 |
03:50 ET | 6932 | 144.89 |
03:52 ET | 10585 | 144.985 |
03:54 ET | 13757 | 145.345 |
03:56 ET | 23583 | 145.435 |
03:57 ET | 23626 | 145.385 |
03:59 ET | 367592 | 145.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 56.6B | -9.3x | --- |
ICON PLC | 26.4B | 38.6x | +4.68% |
Biogen Inc | 33.6B | 29.2x | -18.14% |
Biontech SE | 23.3B | 186.8x | --- |
Grifols SA | 6.2B | 22.9x | --- |
Charles River Laboratories International Inc | 11.0B | 24.9x | +15.57% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $56.6B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.69 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -9.3x |
Price/Sales (TTM) | 11.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.